Find a Tender Service

High speed & ultra Centrifuges, rotors and services

MHRA

Awarded
services
7 lots
Price only

This tender has closed

The submission deadline for this contract has passed. There may be more active services tenders from MHRA, and hundreds more across the UK public sector.

Key details

Contracting authority
MHRA
central gov
Region
London
Delivery: UKI31
Contract value
£6,000,000ex VAT
Submissions closed
4 December 2024
Published
4 October 2024

Procurement

Submission method
Electronic Submission
Procedure type
Restricted procedure
CPV classifications
  • 64121000 Multi-modal courier services

What happened

MHRA awarded this contract to Kuehne + Nagel Limited on 19 Jun 2025.

Description

The Medicines and Healthcare products Regulatory Agency (MHRA) is an executive agency (Agency) of the Department of Health and Social Care in the United Kingdom. It ensures that medicines and medical devices work and are acceptably safe.

MHRA responsibilities include: •Ensuring that medicines, medical devices and blood components meet applicable standards of safety, quality and efficacy. •Ensuring that the supply chain for medicines, medical devices and blood components is safe and secure. •Promoting international standardisation and harmonisation to assure the effectiveness and safety of biological medicines. •Helping to educate the public and healthcare professionals about the risks and benefits of medicines, medical devices and blood components, leading to safer and more effective use. •Supporting innovation and research and development that’s beneficial to public health. •Working collaboratively with partners in the UK and internationally to support our mission to enable the earliest access to safe medicines and medical devices and to protect public health. MHRA's mission is to assure the quality of biological medicines and medical devices. At the heart of this ground breaking research, is the preparation, storage and worldwide distribution of World Health Organization international standards and reference materials as benchmarks for product quality, which are used by industry, regulatory authorities and researchers world-wide. MHRA also produces reagents essential for the production of influenza vaccines each year and quality control reagents for the National Blood Service to help assure the safety of the UK blood supply. We currently distribute materials to in excess of 95 countries around the globe. These materials are transported under three temperature zones, Ambient, chilled 2˚c - 8˚c (ice packs), frozen -20˚C (Dry ice). These consignments have a validated cold chain life of between 96 and 120 hours. Due to the distances involved and the vagaries of local customs practices, firm management and control of the consignments is imperative. During the preceding four years we have seen our volumes grow year on year by the order of 12.5%. It is envisaged that the total expenditure for 2025/26 will be in the approximately £1,200,000 for all movement types. It would be the intention of the Agency to achieve some significant savings through this process whilst retaining high success rates in its delivery objectives. You as our courier, shall be crucial in ensuring this.

Awarded supplier

Supplier
Kuehne + Nagel Limited
Award date
19 June 2025

Contact

Address
10 South Colonnade, Canary Wharf, London, E14 4PU
Contact name
allen chan

Identifiers

Buyer reference
c227271
Notice ID
031978-2024
OCID
ocds-h6vhtk-04a620

Explore related tenders

External ID: fts-ocds-h6vhtk-04a620 • Added 6 August 2026